Publication | Closed Access
Phase II study of docetaxel, cisplatin and 5-fluorouracil (DCF) for metastatic esophageal cancer (OGSG 0403).
55
Citations
20
References
2012
Year
This DCF regimen was well tolerated; the results of this study provide information on the potential of DCF for treatment of patients with metastatic SCCE.
| Year | Citations | |
|---|---|---|
Page 1
Page 1